Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment
ABSTRACT The impact of preexisting antibodies to the four endemic human coronaviruses (ehCoV) (229E, OC43, NL63, and HKU1) on severe (hospitalization) coronavirus disease 2019 (COVID-19) outcomes has been described in small cohorts. Many studies have measured ehCoV 229E, OC43, NL63, and HKU1 antibod...
Main Authors: | Andrew H. Karaba, Trevor S. Johnston, Evan Beck, Oliver Laeyendecker, Andrea L. Cox, Sabra L. Klein, David J. Sullivan |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-02-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.03287-22 |
Similar Items
-
Erratum for Karaba et al., “Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment”
by: Andrew H. Karaba, et al.
Published: (2024-04-01) -
The Proportion of Acute Transfusion Reaction at Outpatient Blood Transfusion Unit In Tertiary Hospital in Indonesia
by: Ahmad Fariz Malvi Zamzam Zein, et al.
Published: (2020-06-01) -
A systematic review of transfusion-transmitted malaria in non-endemic areas
by: Federica Verra, et al.
Published: (2018-01-01) -
Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective
by: Saly Kanj, et al.
Published: (2021-05-01) -
Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma
by: Caro Verbrugghe, et al.
Published: (2024-10-01)